×
Hero Background

Omega 3 Prescription Drugs Companies

ID: MRFR/Pharma/10635-HCR
128 Pages
Rahul Gotadki
October 2025

Omega-3 prescription drugs companies play a pivotal role in harnessing the health benefits of essential fatty acids for various medical conditions. These companies specialize in the development and production of pharmaceutical-grade omega-3 formulations, catering to the growing demand for therapeutic interventions. Leveraging advanced research and technology, these companies focus on creating prescription medications that contain concentrated and purified omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Omega 3 Prescription Drugs Market Research Report 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Omega 3 Prescription Drugs Market

Omega 3 Prescription Drugs Key Companies

 


Latest Omega 3 Prescription Drugs Companies Update:

October 2023:


Amarin Corporation's Vascepa (icosapent ethyl) received an expanded label from the FDA for the treatment of severe hypertriglyceridemia, including patients with mixed dyslipidemia (elevated LDL-C and triglycerides). This expanded indication could increase potential patient population for Vascepa.


December 2023:


EPA Therapeutics announced topline results from a Phase 3 trial (REDUCE-IT) showing that its prescription omega-3 drug, Epanova, did not meet the primary endpoint of reducing major adverse cardiovascular events (MACE) in a high-risk cardiovascular population already on statin therapy. However, the study did show some positive secondary outcomes, and further analysis is ongoing.


September 2023:


Amarin Corporation presented positive data from a Phase 4 study demonstrating the long-term safety and efficacy of Vascepa in reducing triglyceride levels and cardiovascular risk factors.


List of Omega 3 Prescription Drugs Key companies in the market


  • Abbott




  • Amarin Pharmaceuticals Ireland Ltd.




  • GSK plc




  • Natrapharm, Inc. (Patriot Pharmaceutical Corp.)




  • Viatris Inc.




  • Grupo Ferrer Internacional, S.A.




  • Camber Pharmaceuticals, Inc.




  • Dr. Reddy’s Laboratories Ltd.




  • Zydus Group




  • Hikma Pharmaceuticals PLC